Physician profile
Michele Johnson
NPI 1629232301
$612.94
in general payments reported to CMS, 2019-2025
11 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.89 · 2022: $39.81 · 2023: $181 · 2024: $48.05 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.24 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma Global Development | $150.09 | 2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.00 | 2025 | Caplyta |
| Abbvie INC. | $67.44 | 2022-2023 | |
| Hologic Sales and Service, LLC | $45.56 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Minerva Surgical, INC | $44.89 | 2021 | |
| Astellas Pharma US INC | $44.53 | 2023 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $41.98 | 2023 | |
| Supernus Pharmaceuticals, INC. | $26.41 | 2024 | Qelbree |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Millicent US INC | $24.08 | 2025 | Femlyv |
| Organon LLC | $17.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.